Business Context and Reporting Period
Company: Kewaunee Scientific Corporation (KEQU)
Filing Type: Form 8-K (Current Report)
Date of Report: December 4, 2025
Context: The Company entered into a First Amendment to its Loan Agreement with PNC Bank and completed the full repayment of subordinated seller notes related to its November 2024 acquisition of Nu Aire, Inc.
Key Financial Metrics and Debt Activity
- Seller Note Repayment: Full repayment of $23.0 million principal balance plus accrued interest.
- Original Note Terms: 8% per annum interest; maturity date was November 1, 2027.
- New Financing: An additional $10.0 million term loan secured under the amended Loan Agreement.
- Revolving Credit: The Company utilized available funds under its existing revolving line of credit to partially fund the repayment.
- Prepayment Terms: The Seller Notes were prepaid without penalty, premium, or other fees.
Material Changes Versus Prior Period
The filing reports a significant change in the Company's capital structure compared to the prior period:
- Debt Reduction: Elimination of the $23.0 million subordinated seller note obligation.
- Debt Restructuring: Replacement of seller financing with senior bank debt (new term loan and revolver usage).
- Agreement Termination: All obligations and covenants under the original Seller Notes were satisfied and discharged in full.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release (Exhibit 99.1) announcing the transaction. The filing does not provide specific forward-looking guidance, revenue projections, or updated risk factors beyond the execution of the debt restructuring.
Unusual Items: The transaction involves the early retirement of debt originally scheduled to mature in 2027, funded by a mix of new term debt and existing credit facilities.
Important Facts for Investor Verification
- Verify the total cash outflow required for the Seller Note Repayment, including the specific amount of accrued interest paid.
- Review the terms of the new $10.0 million term loan (interest rate, maturity, and covenants) in the First Amendment (Exhibit 10.1).
- Assess the remaining availability under the revolving line of credit after the draw used for this repayment.
- Confirm the impact of this debt swap on the Company's weighted average cost of capital and future interest expense.